RB1 and breast carcinoma: To ensure that this RB-pathway activity signature performed equally well in clinical specimens, we used METABRIC data from 2173 breast cancer cases to identify genes that maintained a high-degree of correlation in clinical cases (Supplementary Fig. 13).